HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vehicle-Based Drug Photosensitivity Testing Discouraged By CTFA

This article was originally published in The Rose Sheet

Executive Summary

Photosensitivity testing of reformulated topical drugs is unnecessary and should not be encouraged by FDA, the Cosmetic, Toiletry and Fragrance Association advises in recent comments on the agency's draft guidance on photosafety testing.
Advertisement

Related Content

NTP Retinyl Palmitate Phototoxicity Studies Opposed By L'Oreal
NTP Retinyl Palmitate Phototoxicity Studies Opposed By L'Oreal
Advertisement
UsernamePublicRestriction

Register

RS007964

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel